Calretinin as a blood-based biomarker for mesothelioma.
Johnen G, Gawrych K, Raiko I, Casjens S, Pesch B, Weber DG, Taeger D, Lehnert M, Kollmeier J, Bauer T, Musk AW, Robinson BWS, Brüning T, Creaney J.
Johnen G, et al. Among authors: kollmeier j.
BMC Cancer. 2017 May 30;17(1):386. doi: 10.1186/s12885-017-3375-5.
BMC Cancer. 2017.
PMID: 28558669
Free PMC article.